Properties (60)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
chemical compound
|
| gptkbp:affiliatedWith |
gptkb:ABC_University
|
| gptkbp:application |
used in pharmaceuticals
|
| gptkbp:built |
formulation challenges
|
| gptkbp:chemicalFormula |
contains a triazine ring
sulfonamide C12H15N3O3S MSDS available pH neutral reacts with amines characterized by NMR effective in vitro |
| gptkbp:clinicalTrials |
Phase II
ongoing clinical trials used for treating infections |
| gptkbp:collaborations |
international collaborations
|
| gptkbp:compatibleWith |
antibacterial
|
| gptkbp:competitors |
ABC-123
high market potential |
| gptkbp:composedOf |
via condensation reaction
|
| gptkbp:dissolved |
soluble in DMSO
|
| gptkbp:drugInterdiction |
oral bioavailability is moderate
|
| gptkbp:environmental_impact |
low environmental impact
|
| gptkbp:environmentalImpact |
low toxicity in animal studies
|
| gptkbp:feedback |
promising clinical outcomes
|
| gptkbp:financial_aid |
stable under normal conditions
|
| gptkbp:formulation |
powder form
|
| gptkbp:funding |
NIH grant
|
| gptkbp:future_plans |
clinical trials
exploration of new formulations |
| https://www.w3.org/2000/01/rdf-schema#label |
WPC-1227
|
| gptkbp:iceClass |
not available
150-155 °C |
| gptkbp:impact |
nausea
high therapeutic index |
| gptkbp:is_aimed_at |
bacterial infections
|
| gptkbp:isATypeOf |
123456-78-9
|
| gptkbp:judgingCriteria |
HPLC
|
| gptkbp:market |
not commercially available
|
| gptkbp:origin |
N-(4-(4-(dimethylamino)phenyl)-6-methyl-1,3,5-triazin-2-yl)benzenesulfonamide
|
| gptkbp:patentAbstract |
cited in several patents
|
| gptkbp:patentAssignee |
gptkb:XYZ_Pharmaceuticals
|
| gptkbp:patentCitation |
US9876543B2
|
| gptkbp:patentExpiration |
2030
|
| gptkbp:patentStatus |
patent pending
|
| gptkbp:publications |
multiple publications
|
| gptkbp:regulatoryCompliance |
approved for research use
|
| gptkbp:related_to |
WPC-1226
|
| gptkbp:releaseYear |
2010
|
| gptkbp:research_areas |
medicinal chemistry
|
| gptkbp:researchInterest |
used in drug discovery
|
| gptkbp:route |
multi-step synthesis
|
| gptkbp:safety |
may cause skin irritation
|
| gptkbp:safety_features |
favorable safety profile
|
| gptkbp:storage |
store in a cool, dry place
|
| gptkbp:targets |
bacteria
specific bacterial strains |
| gptkbp:triggerType |
inhibits bacterial cell wall synthesis
|
| gptkbp:uses |
antimicrobial agent
|
| gptkbp:weight |
283.33 g/mol
|